| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Douglas T Hess | |
| Jonathan S Stamler | |||
| Michael T Forrester | |||
| Brian Lima | |||
| P2860 | cites work | VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR) | Q22008505 |
| Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation | Q22010150 | ||
| Hypoxic Vasodilation by Red Blood Cells: Evidence for an S-Nitrosothiol-Based Signal | Q22306368 | ||
| S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities | Q24304473 | ||
| Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex | Q24308697 | ||
| S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme | Q24530771 | ||
| S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase | Q24536087 | ||
| Cyclic guanosine monophosphate as a mediator of vasodilation | Q24623087 | ||
| Endogenous S-nitrosothiols protect against myocardial injury | Q24658413 | ||
| S-nitrosothiols signal hypoxia-mimetic vascular pathology | Q24675222 | ||
| Human Carbonyl Reductase 1 Is an S-Nitrosoglutathione Reductase | Q27652336 | ||
| Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart | Q27863312 | ||
| FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death | Q28183817 | ||
| A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans | Q28205902 | ||
| Cardiac excitation-contraction coupling | Q28216347 | ||
| Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock | Q28246441 | ||
| Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells | Q42475721 | ||
| Modulation of the K(+) channels encoded by the human ether-a-gogo-related gene-1 (hERG1) by nitric oxide | Q42480179 | ||
| Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. | Q42526186 | ||
| Nitric-oxide-mediated zinc release contributes to hypoxic regulation of pulmonary vascular tone | Q42540322 | ||
| Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance | Q42544768 | ||
| Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms | Q42546244 | ||
| Nitroglycerin-mediated S-nitrosylation of proteins: a field comes full cycle | Q42615544 | ||
| Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases | Q42947736 | ||
| Protein denitrosylation: enzymatic mechanisms and cellular functions. | Q43279398 | ||
| Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase | Q43577448 | ||
| Elevated levels of S-nitrosoalbumin in preeclampsia plasma | Q43633772 | ||
| TNFalpha and oxLDL reduce protein S-nitrosylation in endothelial cells | Q43721284 | ||
| Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms | Q43926534 | ||
| Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus | Q44219619 | ||
| Inhaled NO inhibits platelet aggregation and elevates plasma but not intraplatelet cGMP in healthy human volunteers | Q44443103 | ||
| The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex | Q40273656 | ||
| Nitric oxide: a physiologic messenger molecule | Q40394921 | ||
| S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. | Q40474804 | ||
| HIF-1 alpha protein as a target for S-nitrosation | Q40673725 | ||
| Inhibition of NF-kappa B by S-nitrosylation | Q40809466 | ||
| S-nitrosation controls gating and conductance of the alpha 1 subunit of class C L-type Ca(2+) channels. | Q40817275 | ||
| Oxidative stress and S-nitrosylation of proteins in cells | Q40897269 | ||
| Fas-induced caspase denitrosylation | Q40958925 | ||
| Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation | Q41408037 | ||
| Calcium-dependent release of NO from intracellular S-nitrosothiols | Q41456663 | ||
| A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations | Q41835276 | ||
| Beta-adrenoceptor dysfunction after inhibition of NO synthesis | Q74316942 | ||
| Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide | Q74614332 | ||
| Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats | Q77114829 | ||
| Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice | Q77855505 | ||
| Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets | Q77937629 | ||
| Autoregulation of blood flow by oxygen lack | Q79065859 | ||
| Assessment and application of the biotin switch technique for examining protein S-nitrosylation under conditions of pharmacologically induced oxidative stress | Q80005211 | ||
| Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis | Q80199030 | ||
| Atrial glutathione content, calcium current, and contractility | Q80682915 | ||
| Role of circulating S-nitrosothiols in control of blood pressure | Q81041349 | ||
| Nitric-oxide-mediated zinc release: a new (modulatory) pathway in hypoxic pulmonary vasoconstriction | Q81485706 | ||
| Delayed preconditioning-mimetic actions of nitroglycerin in patients undergoing exercise tolerance tests | Q81752682 | ||
| S-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia | Q82296441 | ||
| Thioredoxin and glutaredoxin systems | Q28271236 | ||
| Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine | Q28291365 | ||
| Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2 | Q28300709 | ||
| Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction | Q28567225 | ||
| Catalysis of S-nitrosothiols formation by serum albumin: the mechanism and implication in vascular control | Q28578257 | ||
| Missing pieces in the NF-kappaB puzzle | Q29547864 | ||
| Protein S-nitrosylation: purview and parameters | Q29615181 | ||
| Physiological functions of thioredoxin and thioredoxin reductase | Q29615600 | ||
| Regulation of angiogenesis by hypoxia: role of the HIF system | Q29619187 | ||
| Hemoglobin conformation couples erythrocyte S-nitrosothiol content to O2 gradients | Q30436525 | ||
| NO/redox disequilibrium in the failing heart and cardiovascular system | Q30475784 | ||
| S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death | Q30843579 | ||
| Export by red blood cells of nitric oxide bioactivity | Q32050891 | ||
| Oxygen regulation of tumor perfusion by S-nitrosohemoglobin reveals a pressor activity of nitric oxide. | Q33214780 | ||
| Impaired vasodilation by red blood cells in sickle cell disease | Q33850500 | ||
| Regulation of platelet granule exocytosis by S-nitrosylation | Q33928520 | ||
| Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture | Q33936994 | ||
| Regulation of HIF-1alpha stability through S-nitrosylation | Q34001616 | ||
| A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension | Q34078525 | ||
| Does nitric oxide modulate mitochondrial energy generation and apoptosis? | Q34127186 | ||
| Nitric oxide regulates endocytosis by S-nitrosylation of dynamin | Q34334925 | ||
| Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research | Q34439279 | ||
| Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation | Q34830350 | ||
| Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung | Q34984262 | ||
| Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice. | Q35004366 | ||
| Protein S-nitrosylation in health and disease: a current perspective | Q35020178 | ||
| Role of oxidative stress in atherosclerosis | Q35088521 | ||
| S-nitrosylation in health and disease | Q35119656 | ||
| Nitric oxide and excitation-contraction coupling | Q35159059 | ||
| Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury | Q35424798 | ||
| Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines | Q35749970 | ||
| The mechanism of cardioprotection by S-nitrosoglutathione monoethyl ester in rat isolated heart during cardioplegic ischaemic arrest | Q35884430 | ||
| Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation | Q35925811 | ||
| Intracellular calcium release and cardiac disease | Q36040986 | ||
| Shear stress increases the amount of S-nitrosylated molecules in endothelial cells: important role for signal transduction | Q44579163 | ||
| Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels | Q44601105 | ||
| Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding. | Q44626801 | ||
| Increased pasma S-nitrosothiol concentrations predict cardiovascular outcomes among patients with end-stage renal disease: a prospective study | Q44745232 | ||
| Red blood cell nitric oxide as an endocrine vasoregulator: a potential role in congestive heart failure | Q44801342 | ||
| Increased neuronal nitric oxide synthase-derived NO production in the failing human heart | Q44863503 | ||
| A platelet secretion pathway mediated by cGMP-dependent protein kinase | Q44997709 | ||
| Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins | Q45004040 | ||
| Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. | Q45091717 | ||
| S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide | Q45111036 | ||
| Role of nitric oxide in Ca2+ sensitivity of the slowly activating delayed rectifier K+ current in cardiac myocytes | Q45166619 | ||
| S-nitrosoalbumin-mediated relaxation is enhanced by ascorbate and copper: effects in pregnancy and preeclampsia plasma | Q45166655 | ||
| Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation | Q45204892 | ||
| Shear flow increases S-nitrosylation of proteins in endothelial cells | Q45324725 | ||
| Nitric oxide increases cardiac IK1 by nitrosylation of cysteine 76 of Kir2.1 channels. | Q45927403 | ||
| A genetic analysis of nitrosative stress | Q46166783 | ||
| Redox- and calmodulin-dependent S-nitrosylation of the KCNQ1 channel | Q46174518 | ||
| Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1). | Q46446913 | ||
| Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols | Q46796433 | ||
| Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure | Q46837814 | ||
| Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. | Q46844231 | ||
| Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy | Q46853314 | ||
| S-nitroso human serum albumin attenuates ischemia/reperfusion injury after cardioplegic arrest in isolated rabbit hearts | Q46859212 | ||
| Knockdown of arginase I restores NO signaling in the vasculature of old rats. | Q46870256 | ||
| Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury | Q46882604 | ||
| S-nitroso human serum albumin reduces ischaemia/reperfusion injury in the pig heart after unprotected warm ischaemia | Q46897899 | ||
| Acute physical exercise reverses S-nitrosation of the insulin receptor, insulin receptor substrate 1 and protein kinase B/Akt in diet-induced obese Wistar rats. | Q46921006 | ||
| Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport | Q46966112 | ||
| Reduced nitric oxide causes age-associated impairment of circadian rhythmicity | Q47961079 | ||
| Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. | Q50773580 | ||
| Nitric oxide: nature's third respiratory gas. | Q51694763 | ||
| Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. | Q51805465 | ||
| High glucose attenuates protein S-nitrosylation in endothelial cells: role of oxidative stress. | Q53533677 | ||
| S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts. | Q53576568 | ||
| Modulation of endotoxin-induced cardiopulmonary dysfunction by S-nitroso-albumin. | Q54546566 | ||
| Xanthine Oxidase-mediated Decomposition ofS-Nitrosothiols | Q56114948 | ||
| Protective effects of S-nitrosoalbumin on lung injury induced by hypoxia-reoxygenation in mouse model of sickle cell disease | Q57426054 | ||
| Effects of Nitroglycerin on Erythrocyte Rheology and Oxygen Unloading | Q57450320 | ||
| Blood Flow Regulation by S-Nitrosohemoglobin in the Physiological Oxygen Gradient | Q58641869 | ||
| S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control | Q59054161 | ||
| Blood traffic control | Q59054300 | ||
| Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms | Q59091659 | ||
| Enhancement of S-Nitrosylation in Glycosylated Hemoglobin | Q59395571 | ||
| Inhibition of Human Platelet Aggregation by Nitric Oxide Donor Drugs: Relative Contribution of cGMP-Independent Mechanisms | Q63488640 | ||
| Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1 | Q71613848 | ||
| Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia | Q73804206 | ||
| Induction of persistent sodium current by exogenous and endogenous nitric oxide | Q73838505 | ||
| Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation | Q74016180 | ||
| Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation | Q74171935 | ||
| Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin | Q36040992 | ||
| Control of cardiac muscle cell function by an endogenous nitric oxide signaling system | Q36047757 | ||
| S-Nitrosylation of cardiac ion channels | Q36079230 | ||
| Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes | Q36300139 | ||
| How do red blood cells cause hypoxic vasodilation? The SNO-hemoglobin paradigm | Q36496546 | ||
| Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. | Q36501983 | ||
| S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity | Q36603140 | ||
| Transport and peripheral bioactivities of nitrogen oxides carried by red blood cell hemoglobin: role in oxygen delivery. | Q36786247 | ||
| Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury | Q36805323 | ||
| Nitric oxide regulation of protein trafficking in the cardiovascular system | Q36816237 | ||
| Cardioprotection in females: a role for nitric oxide and altered gene expression | Q36824758 | ||
| S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking | Q37070857 | ||
| Regulation of the cardiac muscle ryanodine receptor by O(2) tension and S-nitrosoglutathione | Q37085577 | ||
| SDF-1alpha stimulates JNK3 activity via eNOS-dependent nitrosylation of MKP7 to enhance endothelial migration | Q37153723 | ||
| Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein | Q37157872 | ||
| Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin | Q37159291 | ||
| A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury. | Q37227938 | ||
| A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases | Q37352747 | ||
| Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins | Q37369408 | ||
| Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells | Q37376612 | ||
| Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells | Q37386373 | ||
| Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected]. | Q37388923 | ||
| Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. | Q37391969 | ||
| Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection | Q37423503 | ||
| Kinetic and cellular characterization of novel inhibitors of S-nitrosoglutathione reductase | Q37433366 | ||
| Nitric oxide: an endogenous modulator of leukocyte adhesion | Q37519420 | ||
| Hemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation | Q37603613 | ||
| cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. | Q37718172 | ||
| S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. | Q38328824 | ||
| Nitric oxide in the human respiratory cycle. | Q38522683 | ||
| Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. | Q39821682 | ||
| Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases | Q39855219 | ||
| Circulation: overall regulation | Q39895148 | ||
| Thioredoxin catalyzes the denitrosation of low-molecular mass and protein S-nitrosothiols | Q40117517 | ||
| Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. | Q40119917 | ||
| Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2. | Q40179416 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | 633-46 | |
| P577 | publication date | 2010-03-05 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | S-nitrosylation in cardiovascular signaling | |
| P478 | volume | 106 |
| Q34141284 | A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response |
| Q39419240 | A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma |
| Q36541250 | ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance |
| Q36397889 | Aberrant S-nitrosylation mediates calcium-triggered ventricular arrhythmia in the intact heart |
| Q85675091 | Ablation of plasma membrane Ca(2+)-ATPase isoform 4 prevents development of hypertrophy in a model of hypertrophic cardiomyopathy |
| Q90007211 | Acute Nitric Oxide Synthase Inhibition Accelerates Transendothelial Insulin Efflux In Vivo |
| Q43648217 | Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide |
| Q41853908 | Alpha-lipoic acid supplementation protects enzymes from damage by nitrosative and oxidative stress |
| Q28067531 | Altered Calcium Handling and Ventricular Arrhythmias in Acute Ischemia |
| Q33791710 | Analysis of nitroso-proteomes in normotensive and severe preeclamptic human placentas |
| Q33848907 | Antioxidants in experimental ischemia-reperfusion injury of the testis: Where are we heading towards? |
| Q42619765 | Aquaporin-2 promoter is synergistically regulated by nitric oxide and nuclear factor of activated T cells |
| Q35043143 | Arterial Stiffness |
| Q38739380 | Arterial ageing: from endothelial dysfunction to vascular calcification. |
| Q92355916 | Attenuation of Thrombin-Mediated Fibrin Formation via Changes in Fibrinogen Conformation Induced by Reaction with S-nitroso-N-acetylpenicillamine, but not S-nitrosoglutathione |
| Q84393642 | Between nitros(yl)ation and nitration: regulation of thioredoxin-1 in myocardial ischemia/reperfusion injury |
| Q33857887 | Biochemical methods for monitoring protein thiol redox states in biological systems |
| Q36376440 | Biological signaling by small inorganic molecules |
| Q85639237 | C-reactive protein reduces protein S-nitrosylation in endothelial cells |
| Q47916169 | Camptothecin promotes the production of nitric oxide that triggers subsequent S-nitrosoproteome-mediated signaling cascades in endothelial cells. |
| Q36220974 | Can nitric oxide-based therapy prevent bronchopulmonary dysplasia? |
| Q47664602 | Cardiac Ischemia/Reperfusion Injury: The Beneficial Effects of Exercise. |
| Q37805473 | Cardiogenic shock: the role of inflammation |
| Q30429610 | Caveolin-1-eNOS signaling promotes p190RhoGAP-A nitration and endothelial permeability |
| Q37524901 | Cell biology of ischemia/reperfusion injury |
| Q46413960 | Characterization of the electronic states of the biological relevant SSNO molecule |
| Q41413474 | Chasing cysteine oxidative modifications: proteomic tools for characterizing cysteine redox status |
| Q47430972 | Chemical Biology of H2S Signaling through Persulfidation |
| Q34032571 | Chemical characterization of the smallest S-nitrosothiol, HSNO; cellular cross-talk of H2S and S-nitrosothiols |
| Q36138446 | Chemical methods for the direct detection and labeling of S-nitrosothiols |
| Q43575586 | Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles. |
| Q30432944 | Compartmentalized connexin 43 s-nitrosylation/denitrosylation regulates heterocellular communication in the vessel wall |
| Q39209626 | Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease |
| Q54565667 | Crucial role of phospholamban phosphorylation and S-nitrosylation in the negative lusitropism induced by 17β-estradiol in the male rat heart. |
| Q64990264 | Crystal-facet-dependent denitrosylation: modulation of NO release from S-nitrosothiols by Cu2O polymorphs. |
| Q37619143 | Cytochrome c-mediated formation of S-nitrosothiol in cells. |
| Q37148888 | Developmental acceleration of bradykinin-dependent relaxation by prenatal chronic hypoxia impedes normal development after birth |
| Q35206938 | Dietary nitrate is a modifier of vascular gene expression in old male mice. |
| Q41836018 | Dietary nitrate, nitric oxide, and restenosis |
| Q35315038 | Differential regulation of metabolism by nitric oxide and S-nitrosothiols in endothelial cells. |
| Q46675324 | Discovery and microassay of a nitrite-dependent carbonic anhydrase activity by stable-isotope dilution gas chromatography-mass spectrometry |
| Q35556440 | Disruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins |
| Q37605842 | Divide and conquer: the application of organelle proteomics to heart failure |
| Q35837215 | Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function |
| Q35535760 | Effect of sodium nitrite on ischaemia and reperfusion-induced arrhythmias in anaesthetized dogs: is protein S-nitrosylation involved? |
| Q41168936 | Effect of temperature, pH and heme ligands on the reduction of Cygb(Fe(3+)) by ascorbate |
| Q42361387 | Effects of Estrogen, Nitric Oxide, and Dopamine on Behavioral Locomotor Activities in the Embryonic Zebrafish: A Pharmacological Study. |
| Q54982202 | Effects of Nitric Oxide on Voltage-Gated K⁺ Currents in Human Cardiac Fibroblasts through the Protein Kinase G and Protein Kinase A Pathways but Not through S-Nitrosylation. |
| Q34302242 | Effects of intracerebroventricular injections of 5-HT on systemic vascular resistances of conscious rats |
| Q46222743 | Effects of nitric oxide on cell proliferation: novel insights |
| Q38962140 | Emerging pathways driving early synaptic pathology in Alzheimer's disease |
| Q30496168 | Endothelium-dependent coronary vasodilatation requires NADPH oxidase-derived reactive oxygen species |
| Q30398265 | Essential role of hemoglobin beta-93-cysteine in posthypoxia facilitation of breathing in conscious mice |
| Q36515988 | Essential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)ation versus sGC/cGMP/PKG signaling? |
| Q33837078 | Estrogen-responsive nitroso-proteome in uterine artery endothelial cells: role of endothelial nitric oxide synthase and estrogen receptor-β |
| Q36165992 | Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties |
| Q27021649 | Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS |
| Q42408701 | FK506 neuroprotection after cavernous nerve injury is mediated by thioredoxin and glutathione redox systems |
| Q38850764 | Functional Impact of Ryanodine Receptor Oxidation on Intracellular Calcium Regulation in the Heart |
| Q48777749 | Functional differentiation of myoglobin isoforms in hypoxia-tolerant carp indicates tissue-specific protective roles. |
| Q35204833 | Gas what: NO is not the only answer to sexual function |
| Q37311881 | Generating S-nitrosothiols from hemoglobin: mechanisms, conformational dependence, and physiological relevance |
| Q36761919 | Glutathione (GSH) and the GSH synthesis gene Gclm modulate vascular reactivity in mice |
| Q53354190 | Glutathione S-transferase P1 suppresses iNOS protein stability in RAW264.7 macrophage-like cells after LPS stimulation. |
| Q42081344 | Glutathione and thioredoxin type 1 cooperatively denitrosate HepG2 cells-derived cytosolic S-nitrosoproteins |
| Q36801673 | HBOC vasoactivity: interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide species |
| Q34835284 | Heterologous down-regulation of angiotensin type 1 receptors by purinergic P2Y2 receptor stimulation through S-nitrosylation of NF-kappaB. |
| Q38223130 | Homocysteine in renovascular complications: hydrogen sulfide is a modulator and plausible anaerobic ATP generator |
| Q91818920 | Human Relaxin-2 Fusion Protein Treatment Prevents and Reverses Isoproterenol-Induced Hypertrophy and Fibrosis in Mouse Heart |
| Q37314539 | Hydrogen Sulfide Modulates the S-Nitrosoproteome and the Mitochondrial Morphology in Endothelial Cells. |
| Q54341843 | Hydrogen sulfide increases nitric oxide production and subsequent S-nitrosylation in endothelial cells. |
| Q38671519 | Hypoxemia, oxygen content, and the regulation of cerebral blood flow |
| Q30276909 | Impact of dietary nitrate on age-related diastolic dysfunction |
| Q36837643 | Improved tag-switch method reveals that thioredoxin acts as depersulfidase and controls the intracellular levels of protein persulfidation. |
| Q42813773 | In vitro evaluation of the safe margin, antithrombotic and antiproliferative actions for the treatment of restenosis: Nitric oxide donor and polymers |
| Q46420014 | Increased GSNOR Expression during Aging Impairs Cognitive Function and Decreases S-Nitrosation of CaMKIIα. |
| Q84958668 | Increased nitric oxide activity compensates for increased oxidative stress to maintain endothelial function in rat aorta in early type 1 diabetes |
| Q35121810 | Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65 |
| Q27677544 | Insights into BAY 60-2770 Activation and S -Nitrosylation-Dependent Desensitization of Soluble Guanylyl Cyclase via Crystal Structures of Homologous Nostoc H-NOX Domain Complexes |
| Q30417838 | Interaction between nitric oxide signaling and gap junctions: effects on vascular function |
| Q35558818 | Ischaemic preconditioning preferentially increases protein S-nitrosylation in subsarcolemmal mitochondria |
| Q39109413 | Ischemia/Reperfusion |
| Q37327376 | Lack of effect of ODQ does not exclude cGMP signalling via NO-sensitive guanylyl cyclase. |
| Q37180778 | Left Ventricular Transmural Gradient in Mitochondrial Respiration Is Associated with Increased Sub-Endocardium Nitric Oxide and Reactive Oxygen Species Productions |
| Q36421859 | Long-term effect of PROLI/NO on cellular proliferation and phenotype after arterial injury. |
| Q57092646 | Long-term hypoxia uncouples Ca and eNOS in bradykinin-mediated pulmonary arterial relaxation |
| Q34764061 | Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice |
| Q33739415 | Maintenance of S-nitrosothiol homeostasis plays an important role in growth suppression of estrogen receptor-positive breast tumors |
| Q35204865 | Measurement of NO in biological samples |
| Q35166344 | Mechanism of cardioprotection: what can we learn from females? |
| Q28383415 | Mechanism-based triarylphosphine-ester probes for capture of endogenous RSNOs |
| Q31119189 | Mechanisms of nitrosylation and denitrosylation of cytoplasmic glyceraldehyde-3-phosphate dehydrogenase from Arabidopsis thaliana |
| Q38102887 | Methods for detection and characterization of protein S-nitrosylation |
| Q92686456 | Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts |
| Q89397986 | Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials |
| Q33975022 | Mitochondrial ion channels/transporters as sensors and regulators of cellular redox signaling |
| Q37798967 | Modulation of vascular sarco/endoplasmic reticulum calcium ATPase in cardiovascular pathophysiology |
| Q104064577 | NADPH diaphorase detects S-nitrosylated proteins in aldehyde-treated biological tissues |
| Q42475814 | NO control: nitric oxide directly regulates substrate delivery to NOS. Focus on "Nitric oxide can acutely modulate its biosynthesis through a negative feedback mechanism on L-arginine transport in cardiac myocytes". |
| Q46425198 | NO-dependent CaMKII activation during β-adrenergic stimulation of cardiac muscle. |
| Q34062825 | Neural programming of mesenteric and renal arteries |
| Q26827970 | New insights into male (in)fertility: the importance of NO |
| Q36138609 | Nitric Oxide Induces Cardiac Protection by Preventing Extracellular Matrix Degradation through the Complex Caveolin-3/EMMPRIN in Cardiac Myocytes. |
| Q36104908 | Nitric Oxide Synthase 1 Modulates Basal and β-Adrenergic-Stimulated Contractility by Rapid and Reversible Redox-Dependent S-Nitrosylation of the Heart |
| Q53795544 | Nitric oxide and S-nitrosoglutathione function additively during plant immunity. |
| Q39240558 | Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system |
| Q38423876 | Nitric oxide and the cardiovascular system |
| Q36966244 | Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature |
| Q35435319 | Nitric oxide metabolism in asthma pathophysiology |
| Q37986339 | Nitric oxide signaling in hypoxia |
| Q49501122 | Nitric oxide signalling in cardiovascular health and disease. |
| Q37917873 | Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: from contractility to remodeling |
| Q37987724 | Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases |
| Q38112049 | Nitric oxide transport in blood: a third gas in the respiratory cycle |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q37927098 | Nitric oxide: orchestrator of endothelium-dependent responses |
| Q41470560 | Nitrite-mediated reduction of macrophage NADPH oxidase activity is dependent on xanthine oxidoreductase-derived nitric oxide but independent of S-nitrosation. |
| Q38875536 | Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome |
| Q36693997 | Nitrosative protein oxidation is modulated during early endotoxemia. |
| Q42668752 | Nitroso-redox imbalance affects cardiac structure and function. |
| Q38851306 | Nitrosopersulfide (SSNO-) decomposes in the presence of sulfide, cyanide or glutathione to give HSNO/SNO-: consequences for the assumed role in cell signalling |
| Q55241880 | Nrf2 Deficiency Unmasks the Significance of Nitric Oxide Synthase Activity for Cardioprotection. |
| Q90333242 | Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP) |
| Q38545010 | Persulfidation (S-sulfhydration) and H2S. |
| Q46241504 | Pharmacologic Targeting of Red Blood Cells to Improve Tissue Oxygenation |
| Q39558562 | Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo |
| Q33974608 | Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice. |
| Q27673395 | Post-translational S-Nitrosylation Is an Endogenous Factor Fine Tuning the Properties of Human S100A1 Protein |
| Q21129237 | Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium |
| Q37629224 | Postconditioning leads to an increase in protein S-nitrosylation. |
| Q33752212 | Preventing ischemic brain injury after sudden cardiac arrest using NO inhalation |
| Q35408828 | Priming of hypoxia-inducible factor by neuronal nitric oxide synthase is essential for adaptive responses to severe anemia |
| Q26752842 | Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications |
| Q38851156 | Protein Regulation in Signal Transduction |
| Q47410870 | Protein S-Nitrosylation: Determinants of Specificity and Enzymatic Regulation of S-Nitrosothiol-Based Signaling. |
| Q38199441 | Protein S-nitrosylation in preconditioning and postconditioning |
| Q34138958 | Proteomic and mass spectroscopic quantitation of protein S-nitrosation differentiates NO-donors |
| Q38115211 | Proteomic approaches to evaluate protein S-nitrosylation in disease. |
| Q37980244 | Proteomics insights into deregulated protein S-nitrosylation and disease |
| Q35097658 | Quantification of cysteinyl S-nitrosylation by fluorescence in unbiased proteomic studies |
| Q37082092 | Quantitative Proteomics Analysis of VEGF-Responsive Endothelial Protein S-Nitrosylation Using Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and LC-MS/MS |
| Q36403046 | Quantitative proteomics reveals differential regulation of protein expression in recipient myocardium after trilineage cardiovascular cell transplantation |
| Q37166776 | Quantitative site-specific reactivity profiling of S-nitrosylation in mouse skeletal muscle using cysteinyl peptide enrichment coupled with mass spectrometry |
| Q35906815 | Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates |
| Q37679633 | Recent insights in the paracrine modulation of cardiomyocyte contractility by cardiac endothelial cells. |
| Q60046133 | Redox Dependent Modifications of Ryanodine Receptor: Basic Mechanisms and Implications in Heart Diseases |
| Q27000640 | Redox modification of cell signaling in the cardiovascular system |
| Q28392484 | Redox regulation of endothelial cell fate |
| Q36770811 | Redox regulation of ion channels in the pulmonary circulation |
| Q34629326 | Redox signaling in cardiac myocytes. |
| Q26785302 | Regulation of CaMKII signaling in cardiovascular disease |
| Q24300987 | Regulation of cardiovascular cellular processes by S-nitrosylation |
| Q35721799 | Regulation of cell physiology and pathology by protein S-glutathionylation: lessons learned from the cardiovascular system. |
| Q30406156 | Regulation of cellular communication by signaling microdomains in the blood vessel wall |
| Q36927675 | Regulation of gap junctions by nitric oxide influences the generation of arrhythmias resulting from acute ischemia and reperfusion in vivo |
| Q34170269 | Regulation of mitochondrial processes by protein S-nitrosylation |
| Q60173945 | Relevance of peroxynitrite formation and 3-nitrotyrosine on spermatozoa physiology |
| Q58556725 | Resistance exercise mediates remote ischemic preconditioning by limiting cardiac eNOS uncoupling |
| Q36375745 | Reversible inactivation of dihydrolipoamide dehydrogenase by Angeli's salt. |
| Q42583230 | Review focus on inorganic nitrite and nitrate in cardiovascular health and disease. |
| Q90569411 | Role of Nitric Oxide Carried by Hemoglobin in Cardiovascular Physiology: Developments on a Three-Gas Respiratory Cycle |
| Q49993782 | Role of Thioredoxin in Age-Related Hypertension. |
| Q30393764 | Role of nitric oxide-containing factors in the ventilatory and cardiovascular responses elicited by hypoxic challenge in isoflurane-anesthetized rats |
| Q35948515 | Role of reactive oxygen and nitrogen species in the vascular responses to inflammation |
| Q37967558 | Routes for formation of S-nitrosothiols in blood |
| Q43806209 | Ru(III)(EDTA) mediated S-nitrosylation of cysteine by nitrite |
| Q88409211 | S-Nitrosylation of Prostacyclin Synthase Instigates Nitrate Cross-Tolerance In Vivo |
| Q36291728 | S-Nitrosylation of Sarcomeric Proteins Depresses Myofilament Ca2+)Sensitivity in Intact Cardiomyocytes. |
| Q90234537 | S-Persulfidation: Chemistry, Chemical Biology, and Significance in Health and Disease |
| Q41981524 | S-glutathionylation: a redox-sensitive switch participating in nitroso-redox balance |
| Q35172025 | S-nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats |
| Q39181217 | S-nitrosothiol signaling regulates liver development and improves outcome following toxic liver injury |
| Q36822549 | S-nitrosylation of ARH is required for LDL uptake by the LDL receptor |
| Q88596912 | S-nitrosylation of NOS pathway mediators in the penis contributes to cavernous nerve injury-induced erectile dysfunction |
| Q90057369 | S-nitrosylation of surfactant protein-D: a proinflammatory posttranslational modification |
| Q102058903 | S-nitrosylation-mediated activation of a histidine kinase represses the type 3 secretion system and promotes virulence of an enteric pathogen |
| Q35091511 | S-nitrosylation-regulated GPCR signaling |
| Q36497166 | S-nitrosylation: integrator of cardiovascular performance and oxygen delivery |
| Q37502786 | Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications |
| Q33891679 | Single-nucleotide variations in cardiac arrhythmias: prospects for genomics and proteomics based biomarker discovery and diagnostics |
| Q36820423 | Skeletal muscle function during exercise-fine-tuning of diverse subsystems by nitric oxide |
| Q92938164 | Sodium nitrite improves hypertension-induced myocardial dysfunction by mechanisms involving cardiac S-nitrosylation |
| Q37234894 | Soluble guanylate cyclase modulates alveolarization in the newborn lung |
| Q34784680 | Soluble guanylate cyclase-α1 is required for the cardioprotective effects of inhaled nitric oxide |
| Q58075704 | Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation |
| Q37204142 | Specificity in S-nitrosylation: a short-range mechanism for NO signaling? |
| Q26823024 | Strategies for profiling native S-nitrosylation |
| Q37938337 | Sub-cellular targeting of constitutive NOS in health and disease |
| Q36661502 | Targeted Nitric Oxide Delivery by Supramolecular Nanofibers for the Prevention of Restenosis After Arterial Injury |
| Q34395219 | Targeting aldehyde dehydrogenase 2: new therapeutic opportunities |
| Q27023252 | Targeting the redox balance in inflammatory skin conditions |
| Q58214160 | Tetrahydrobiopterin modulates ubiquitin conjugation to UBC13/UBE2N and proteasome activity by S-nitrosation |
| Q60584712 | The Emerging Role of Protein S-Nitrosylation in Cancer Metastasis |
| Q37533678 | The Relationship between Estrogen and Nitric Oxide in the Prevention of Cardiac and Vascular Anomalies in the Developing Zebrafish (Danio Rerio) |
| Q34579428 | The SNO-proteome: causation and classifications |
| Q37665613 | The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms. |
| Q36498641 | The role of nitric oxide on rosuvastatin-mediated S-nitrosylation and translational proteomes in human umbilical vein endothelial cells |
| Q39202443 | The role of nitrogen oxides in human adaptation to hypoxia |
| Q34212337 | The science of stroke: mechanisms in search of treatments |
| Q41896747 | Thioredoxin increases exocytosis by denitrosylating N-ethylmaleimide-sensitive factor |
| Q37714134 | Top-down proteomics of a drop of blood for diabetes monitoring |
| Q46528720 | Toward the laboratory identification of [O,N,S,S] isomers: Implications for biological NO chemistry |
| Q36848221 | Transnitrosylation: A Factor in Nitric Oxide-Mediated Penile Erection. |
| Q57092049 | Ventilatory and cerebrovascular regulation and integration at high-altitude |
| Q30415114 | Ventilatory responses during and following exposure to a hypoxic challenge in conscious mice deficient or null in S-nitrosoglutathione reductase |
| Q35254222 | dbSNO 2.0: a resource for exploring structural environment, functional and disease association and regulatory network of protein S-nitrosylation |
| Q64073142 | nNOS/GSNOR interaction contributes to skeletal muscle differentiation and homeostasis |
Search more.